Table 1.
Variable | Non-PHT group (n = 14) |
PHT group (n = 11) |
P |
---|---|---|---|
Age, years | 58 ± 8 | 62 ± 13 | 0.37 |
Male sex, no. (%) of patients | 3 (21.4) | 4 (36.4) | |
BMI | 29.1 ± 5.9 | 28.5 ± 6.5 | 0.8 |
Functional status | |||
NYHA class 1∶2∶3∶4 | 1∶12∶1∶0 | 0∶6∶5∶0 | |
Medication use | |||
Calcium channel antagonist | 4 | 6 | |
Hemodynamic data | |||
PASP, mmHg | 35.4 ± 8.8 | 60.2 ± 22.8 | 0.001 |
PADP, mmHg | 14.4 ± 5.8 | 22.4 ± 10.1 | 0.02 |
mPAP, mmHg | 23.9 ± 7.5 | 38.5 ± 14.5 | 0.003 |
PCWP, mmHg | 12.1 ± 5.7 | 17.5 ± 7.5 | 0.05 |
PVR, Wood units | 2.0 ± 0.8 | 3.4 ± 3.0 | 0.11 |
HR, beats/min | 73 ± 14 | 74 ± 14 | 0.81 |
CO, L/min | 6.0 ± 1.7 | 6.5 ± 1.9 | 0.52 |
SV, mL | 83.3 ± 17.7 | 89.2 ± 21.1 | 0.45 |
Data are mean value ± standard deviation, unless otherwise indicated. BMI: body mass index; NYHA: New York Heart Association; PASP: pulmonary artery systolic pressure; PADP: pulmonary artery diastolic pressure; mPAP: mean pulmonary artery pressure; PCWP: pulmonary capillary wedge pressure; PVR: pulmonary vascular resistance; HR: heart rate; CO: cardiac output; SV: stroke volume.